# Dysport Dose-Ranging Treatment of Platysmal Bands

> **NCT04886167** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Clinical Testing of Beverly Hills** · enrollment: 30 (estimated)

## Conditions studied

- Platysma Bands

## Interventions

- **DRUG:** AbobotulinumtoxinA

## Key facts

- **NCT ID:** NCT04886167
- **Lead sponsor:** Clinical Testing of Beverly Hills
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-30
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886167, "Dysport Dose-Ranging Treatment of Platysmal Bands". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04886167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*